Health policy
Democrats ask drugmakers to disclose Trump pricing agreements
Democrats want unredacted agreements to examine what drugmakers receive in return for lowering Medicaid prices.
Congressional Democrats are asking pharmaceutical companies with drug-pricing agreements with the Trump administration to provide unredacted copies, according to The Hill and Endpoints News. The request was sent Monday, a source familiar with the communications told Endpoints News. The Hill reported that the request came from Reps. Frank Pallone Jr., Richard Neal and Bobby Scott, and Sen. Ron Wyden.
The lawmakers want to know what companies receive in return for agreeing to lower prices for Medicaid, and to examine administration claims about savings. Under the agreements, manufacturers have pledged not to charge more than the lowest international price for select products, The Hill reported. Companies and Trump administration officials have described the agreements as confidential. If companies cannot provide the details, The Hill reported, they were asked to meet with lawmakers in the next two weeks to discuss how they would fulfill the request.
